Michael J. Martens

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu et al. · New England Journal of Medicine · 2023 · 547 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +16

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Lori Muffly, Marcelo C. Pasquini, Michael J. Martens et al. · Blood · 2017 · 296 citations · Full text

Medicine, Geriatric Medicine, Hematology +14

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

Ryotaro Nakamura, Wael Saber, Michael J. Martens et al. · Journal of Clinical Oncology · 2021 · 141 citations · Full text

Medicine, Geriatric Medicine, Hematology +15

Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

Joseph Pidala, Mehdi Hamadani, Peter Dawson et al. · Blood · 2019 · 84 citations · Full text

Pharmacy, Immunology, Immunotherapy +6

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study

Jurjen Versluis, Wael Saber, Harrison Tsai et al. · Journal of Clinical Oncology · 2023 · 70 citations · Full text

Medicine, Genetics, Hematology +12